Biogena Group Invest AG (WBO:BIO) Total Liabilities: €0.06 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:BIO Biogena Group Invest AG WBO:BIO
59 GF Score
Price €5.55
GF Value €3.48
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Biogena Group Invest AG Total Liabilities?

Biogena Group Invest AG WBO:BIO +3.74% 59 Total Liabilities is €0.06 Mil as of Jan. 2026. GuruFocus rates WBO:BIO with a GF Score™ of 59/100 and a GF Value™ of €3.48 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Biogena Group Invest AG's Total Liabilities for the quarter that ended in Jan. 2026 was €0.06 Mil.

Biogena Group Invest AG's quarterly Total Liabilities declined from Jan. 2024 (€0.37 Mil) to Jan. 2025 (€0.24 Mil) and declined from Jan. 2025 (€0.24 Mil) to Jan. 2026 (€0.06 Mil).

Biogena Group Invest AG's annual Total Liabilities declined from Jan. 2024 (€0.37 Mil) to Jan. 2025 (€0.24 Mil) and declined from Jan. 2025 (€0.24 Mil) to Jan. 2026 (€0.06 Mil).


Biogena Group Invest AG Total Liabilities Historical Data

* Premium members only.

The historical data trend for Biogena Group Invest AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogena Group Invest AG Total Liabilities Chart

Biogena Group Invest AG Annual Data
Trend Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Total Liabilities
Get a 7-Day Free Trial 0.13 0.18 0.37 0.24 0.06

Biogena Group Invest AG Semi-Annual Data
Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Total Liabilities Get a 7-Day Free Trial 0.13 0.18 0.37 0.24 0.06
WBO:BIO
59GF Score
Biogena Group Invest AG WBO:BIO
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biogena Group Invest AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Biogena Group Invest AG's Total Liabilities for the fiscal year that ended in Jan. 2026 is calculated as

Total Liabilities=Total Assets (A: Jan. 2026 )-Total Equity (A: Jan. 2026 )
=8.86-8.797
=0.06

Biogena Group Invest AG's Total Liabilities for the quarter that ended in Jan. 2026 is calculated as

Total Liabilities=Total Assets (Q: Jan. 2026 )-Total Equity (Q: Jan. 2026 )
=8.86-8.797
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €0.06 Mil mean?
Biogena Group Invest AG (WBO:BIO) has a Total Liabilities of €0.06 Mil as of Jan. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Biogena Group Invest AG and its competitors.
Is Biogena Group Invest AG's Total Liabilities too high?
Biogena Group Invest AG's current Total Liabilities is €0.06 Mil. Overall, Biogena Group Invest AG has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biogena Group Invest AG's Total Liabilities compare to KHC and GIS?
Biogena Group Invest AG's Total Liabilities of €0.06 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Consumer Packaged Goods company?
A good Total Liabilities depends on the Consumer Packaged Goods industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Biogena Group Invest AG and its competitors. Biogena Group Invest AG's current Total Liabilities is €0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogena Group Invest AG stock overvalued right now?
Based on GuruFocus' analysis, Biogena Group Invest AG (WBO:BIO) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.48, compared to a current price of €5.55 — trading 59.5% above its estimated fair value. The current Total Liabilities is €0.06 Mil. Biogena Group Invest AG's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Biogena Group Invest AG (WBO:BIO), the current Total Liabilities is €0.06 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biogena Group Invest AG (WBO:BIO) Overvalued in 2026?

Based on GuruFocus' analysis, Biogena Group Invest AG stock appears to be overvalued. The current stock price of €5.55 is trading 59.5% above its estimated GF Value™ of €3.48. GuruFocus considers Biogena Group Invest AG to be Significantly Overvalued.

Key valuation signals for WBO:BIO:

  • Total Liabilities: €0.06 Mil
  • GF Value™: €3.48 vs. price of €5.55 (59.5% above fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the WBO:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biogena Group Invest AG Business Description

Address Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
59GF Score

Get the complete analysis for WBO:BIO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.55
Price
€3.48
GF Value